Determinants of facilitated health insurance enrollment for patients with HIV disease, and impact of insurance enrollment on targeted health outcomes

Table 2 Health outcome comparisons among Insured AIDS Drug Assistance Program participants vs Not Insured

	Insured (n = 99)		Not Insured (n = 101)
	Mean	SD	Mean	SD	p-value
PDC medication refill ratio/yr	78.65	22.18	61.45	36.12	<.0001
Total count HIV clinic visits	2.36	1.11	1.75	1.08	.0001
Total count medications	5.64	4.74	4.08	3.61	.0096
Total count HIV medications	1.98	1.15	1.69	1.25	.093
Lab values
CD4 count	701.42	360.69	615.52	384.29	.13
Low-density lipoprotein	100.40	35.54	92.29	29.84	.19
Diastolic blood pressure	127.20	16.49	130.10	20.89	.28
Systolic blood pressure	80.57	9.28	79.94	9.34	.65
Body Mass Index	26.95	8.56	26.27	5.87	.54
	Number	%	Number	%	p-value
HIV viral load undetectable?
Yes	84	84.8%	59	58.4%	<.0001
No	15	15.2%	42	41.6%
Accessed other type doctors?
Yes	61	61.6%	32	31.7%	<.0001
No	38	38.4%	69	68.3%
“No Shows” in HIV clinic?
Yes (one or more)	32	32.3%	52	51.5%	.0060
No	67	67.7%	49	48.5%
ER Visits?
Yes	14	14.1%	14	13.9%	.95
No	85	85.9%	87	86.1%
Hospitalized?
Yes	5	5.1%	9	8.9%	.41
No	94	94.9%	92	91.1%
Diabetes Mellitus diagnosis?
Yes	6	6.1%	4	4.0%	.75
No	93	93.9%	86	85.4%
Hyperlipidemia diagnosis?
Yes	25	25.2%	9	8.9%	.0064
No	74	74.7%	81	80.2%
Hypertension diagnosis?
Yes	21	21.2%	18	17.8%	.84
No	78	78.8%	72	71.3%

Abbreviation PDC Proportion Days Covered, calculated by dividing the coverage days accounted for by the patient’s refill records, by the days in the coverage year

ISSN: 1471-2334